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Abstract
Hypoxia increases the ventilatory response to exercise, which leads to hyperventilation-induced hypocapnia and
subsequent reduction in cerebral blood flow (CBF). We studied the effects of adding CO2 to a hypoxic inspired gas on CBF
during heavy exercise in an altitude naı¨ve population. We hypothesized that augmented inspired CO2 and hypoxia would
exert synergistic effects on increasing CBF during exercise, which would improve exercise capacity compared to hypocapnic
hypoxia. We also examined the responsiveness of CO2 and O2 chemoreception on the regulation ventilation (V
:
E) during
incremental exercise. We measured middle cerebral artery velocity (MCAv; index of CBF), V
:
E, end-tidal PCO2, respiratory
compensation threshold (RC) and ventilatory response to exercise (V
:
E slope) in ten healthy men during incremental cycling
to exhaustion in normoxia and hypoxia (FIO2 = 0.10) with and without augmenting the fraction of inspired CO2 (FICO2).
During exercise in normoxia, augmenting FICO2 elevated MCAv throughout exercise and lowered both RC onset andV
:
E
slope below RC (P,0.05). In hypoxia, MCAv and V
:
E slope below RC during exercise were elevated, while the onset of RC
occurred at lower exercise intensity (P,0.05). Augmenting FICO2 in hypoxia increased V
:
E at RC (P,0.05) but no difference
was observed in RC onset, MCAv, or V
:
E slope below RC (P.0.05). The V
:
E slope above RC was unchanged with either
hypoxia or augmented FICO2 (P.0.05). We found augmenting FICO2 increased CBF during sub-maximal exercise in
normoxia, but not in hypoxia, indicating that the ‘normal’ cerebrovascular response to hypercapnia is blunted during
exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory reserve. This finding may explain the lack of
improvement of exercise capacity in hypoxia with augmented CO2. Our data further indicate that, during exercise below RC,
chemoreception is responsive, while above RC the ventilatory response to CO2 is blunted.
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Introduction
At high intensities of exercise in normoxia, above the respiratory
compensation threshold (RC), hyperventilation-induced hypocap-
nia constricts the cerebral vessels, thereby reducing cerebral blood
flow (CBF) and lowering cerebral oxygen delivery [1–3]. In
conditions of hypoxia, in spite of hypoxic vasodilation, the
hypocapnia-induced limitation of CBF at high exercise intensities
is further aggravated due to a greater ventilatory drive. Such a
limitation of CBF might lead to inadequate cerebral O2 delivery,
triggering early motor drive withdrawal, thus limiting exercise
performance in hypoxia [4,5]. In support, several studies found a
relationship between performance and cerebral deoxygenation in
hypoxia using various exercise modes such as repeated sprints [6],
incremental exercise [7,8], and static maximal muscle contraction
to exhaustion [9–12]. Similarly, under normoxic conditions,
exacerbation of exercise induced cerebral deoxygenation, by
administering a non-selective beta-blocker, is accompanied by
impaired maximal exercise performance [13]. This has led to the
hypothesis that an exaggerated hyperventilation-induced hypo-
capnia and subsequent reduction in CBF during heavy exercise
might account, in part, for the impaired performance in hypoxia.
Recently, studies have assessed the effect of preventing the
normal drop in end-tidal PCO2 on CBF and exercise performance
in normoxia [14] and hypoxia [15,16]. Subudhi et al., [15]
reported impaired exercise capacity at 1,600 m and 4,875 m
(hypobaric chamber) when they clamped end-tidal PCO2
(PETCO2) either: 1) at 50 mmHg throughout incremental exercise
or 2): at 40 mmHg from ,75% maximal work rate until
exhaustion. Siebenmann et al., [16] completed those observations
by investigating, at a more moderate altitude (3,454 m), the
impact of clamping PETCO2 at 40 mmHg, on performance. Both
of these studies found clamping PETCO2 increased MCAv and
attenuated the decrease in cerebral oxygenation, but slightly
decreased peak power output without affecting maximal oxygen
uptake. Subudhi et al., [15] found ventilation (V
:
E) was elevated
(by ,50 L/min) during submaximal exercise intensities (37 and
75% of maximal hypoxic work rate) with PETCO2 clamping,
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compared to without added CO2. As such, they attributed the
reduced performance with CO2 clamping to earlier functional
limitation by the respiratory system associated with CO2
breathing. Since these studies were carried out in subjects living
at moderate altitude [15] and in low altitude residents following a
day spent at high altitude[16], respectively, both conditions
accompanied by enhanced cerebrovascular and ventilatory
responsiveness to CO2 [17,18], the acute effect of augmented
FICO2 and hypoxia on CBF during exercise in an altitude-naı¨ve
population remained unclear.
For climbing 8,000 m peaks, a strong ventilatory response at
altitude is believed to be a factor for success [19], but increases the
risk of brain damage because of excessive hyperventilation-
induced cerebral hypoxemia [20]. By contrast, Bernardi et al.,
[21] found that acclimatized elite climbers with a smaller
ventilatory response to hypoxia at 5,200 m were more successful
climbing to extreme altitude (Everest and K2), perhaps due to a
greater ventilatory reserve (difference between maximal voluntary
ventilation and effective minute ventilation) at these altitudes.
Therefore, the effect of augmenting FICO2 on ventilation during
exercise is of interest, particularly in the presence of enhanced
ventilatory drive associated with hypoxia.
We tested the hypotheses that, in non-altitude acclimatized
subjects, increasing PETCO2 during incremental exercise in
normobaric hypoxia would: i) further augment CBF during
exercise in hypoxia and improve exercise capacity; and ii)
exacerbate the increase in ventilation at sub-maximal exercise
intensities but not at maximal effort.
Methods
Ethics
The study was approved by the Research Ethical Committee of
the University Hospitals of Geneva and conformed to the
standards set by the Declaration of Helsinki. All subjects were
informed regarding the procedures of this study, and informed
signed consent was given prior to participation.
Subjects
Ten healthy male subjects with a mean age of 2463 yr (mean6
SD), a body mass index of 22.762.4 kg/m2 and V
:
O2max of
58.3610.5 ml/min/kg participated in this study. Subjects were
non-smokers, had no previous history of cardiovascular, cerebro-
vascular, or respiratory disease and were not taking any
medication. All the subjects were residents of Geneva, Switzerland
(,400 m) and partook in regular exercise (3–6 h per week); none
were acclimatized to altitude (i.e., they had not travelled to
altitudes .1,000 m in the past 2 months).
Experimental design
The subjects visited the laboratory on five occasions. After a full
familiarization with the experimental procedures outlined below
(visit one), subjects underwent four experimental exercise trials in a
randomized, single-blind and balanced fashion (to prevent order
effects), with a 3-day washout period between each experimental
session, consisting of the following conditions: i) control normoxia
(ambient air, 389 m); ii) augmented FICO2 in normoxia; iii)
control hypoxia (normobaric simulated altitude, 5,000 m); and iv)
augmented FICO2 in hypoxia. Before each experimental session,
the subjects were asked to abstain from caffeine for 12 h and heavy
exercise, and from alcohol for 24 h. Each experimental testing
session comprised 20 min instrumentation followed by a 4 min
resting baseline collection with the subject breathing room-air and
seated on an electronically braked cycle ergometer (Ergoselect
100, Ergoline GmbH, Bitz, Germany). During the hypoxia and
augmented FICO2 trials, the subjects were then switched to a gas
mixing system (described below), breathing the respective gas
mixtures for an additional 4 min resting baseline (condition
baseline) prior to the incremental cycling test.
Exercise test
The subjects were instructed to begin cycling at 0 watts at a
pedaling rate of 70 rpm. The work rate was increased by 0.5 watts
every second (30 W/min) thereafter until the subject reached
voluntary exhaustion. Throughout each experimental session, the
subjects wore a nose-clip and breathed through a mouthpiece
attached to a low resistance one-way non-rebreathing valve (Hans-
Rudolph 2700, Kansas City, USA). The hypoxia and augmented
FICO2 were achieved using a modified gas mixing system
(Altitrainer, SMTec, Nyon, Switzerland), which has been previ-
ously described in detail [14]. In brief, additional CO2 was bled
into the inspired gas mixture under constant feedback of on-screen
PETCO2 and FICO2 was constantly adapted as to keep PETCO2
to a target value of approximately 45 mmHg during both
normoxia and hypoxia. The FIO2 was held constant at either
0.21 (normoxia, ambient air) or 0.10 (hypoxia). The subjects
breathed through the same circuit in all four conditions and were
kept unaware to what gas mixture they were breathing and were
naive to the rationale of the study. For each subject the
experiments were carried out at the same time of day under
consistent laboratory conditions (temperature 22.360.5uC, hu-
midity 2767%, barometric pressure 72564 mmHg).
Measurements
Respiratory variables. Gas exchange was monitored on a
breath-by-breath basis (Medgraphics CPX, Loma Linda, USA)
measuring flow at the mouth with a Pitot tube and the fractions of
inspired and expired O2 and CO2 with fast responding gas
analyzers (infrared and paramagnetic) integrated in the system.
Ventilation (V
:
E) was derived from the flow signal and expressed in
body temperature and pressure saturated (BTPS) and L/min,
respectively. The partial pressure of end-tidal O2 (PETO2), CO2
(PETCO2), O2 consumption (V
:
O2) and CO2 production (V
:
CO2)
were calculated by the gas analysis system. Prior to each
experimental session the system was calibrated using a 3-L syringe
(M9474, Medikro Oy, Finland) and precision gas mixtures of
known O2 and CO2 concentrations.
Cerebrovascular and cardiovascular variables. Bilateral
middle cerebral artery blood flow velocities (MCAv: as index of
CBF) were measured in the middle cerebral arteries using a 2-
MHz pulsed Doppler ultrasound system (ST3, Spencer technol-
ogy, Seattle, USA). The Doppler ultrasound probes were
positioned over the temporal windows and held firmly in place
with an adjustable headband (Marc 600 Headframe, Spencer
technology, Seattle, USA). The signals were at depths ranging
from 43 to 54 mm. Signal quality was optimized and an M-mode
screen shot was recorded to facilitate subsequent probe place-
ments. In our hands, day-to-day reproducibility of MCAv has a
coefficient of variation of ,10%. The bilateral MCAv were
averaged to represent an index of global CBF during rest and
exercise. Heart rate was measured using a thoracic belt and
recorded directly onto a PC via a wireless receiver pod (PC-POD,
Suunto, Vantaa, Finland). Peripheral O2 saturation (SpO2) was
measured from the right ear lobe using pulse oximetry (Satlite,
Datex, Helsinki, Finland, and ML320 Oximeter Pod, ADInstru-
ments, Bella Vista, Australia). Blood pressure was measured with
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an automated arm sphygmomanometer (Ergoselect 100, Ergoline
GmbH, Bitz, Germany).
Perceived exertion. During exercise, the subjects were asked
to score their perceived exercise exertion on the 0–10 Borg scale
every minute [22].
Data and statistical analysis
Respiratory compensation threshold and ventilatory
response to exercise. The respiratory compensation threshold
(RC) was obtained using the v-slope method previously described
by Beaver et al., [23]. The assessment of the ventilatory response
to exercise (i.e., the slope of V
:
E rise during exercise: V
:
E-slope to
power output) has been previously described [24,25]. In brief,
breath-by-breath V
:
E points were plotted against mechanical
power output and a least squares regression was used to determine
the V
:
E-slope to exercise above and below RC.
Statistical analysis. Resting values were obtained by aver-
aging the data obtained in the last two minutes of the four minutes
resting periods just prior to exercise. For the incremental exercise,
we took the last 20 sec of every 10% increase in exercise intensity
until exhaustion (100%). We then averaged all of the 20 sec
segments of the data to obtain a single mean value for each variable
during all four experimental conditions. The effects of hypoxia and
augmenting FICO2 on cardiorespiratory and cerebrovascular
responses at rest were assessed using two-way repeated-measures
ANOVA with a-level of P,0.05 (IBM SPSS Statistics version
21.0, IBM Corporation, Armonk, USA). Likewise, two-way
repeated measure ANOVA was used to assess the effects of
hypoxia and augmenting FICO2 on these variables during
incremental exercise. For significant interactions between hypoxia
and augmenting FICO2, four pairwise comparisons (Bonferroni
corrected) were performed to isolate the effect of hypoxia and
augmenting FICO2 on the dependent measures within subjects
with a a-level of 0.0125, indicated where appropriate with the
superscript B. Trends were considered when P,0.10. All data are
reported as means 6 SD.
Results
All ten subjects completed the experimental protocol. Due to
poor gas exchange traces, one subject had to repeat the augmented
FICO2 in hypoxia trial. Two subjects had to repeat their control
normoxia trials, as they initially did not maintain a pedaling rate of
70 rpm during high intensity exercise. One subject reported
respiratory dyspnea during exercise in augmented FICO2, in
hypoxia, while another reported a mild headache lasting 20 min
following the control hypoxia trial. No other subjects reported any
side effects such as headache or dyspnea following the experi-
ments. Due to poor blood pressure signals during exercise, we
were unable to carry out repeated-measures ANOVA analysis on
the MAP data during exercise.
Resting variables (Table 1)
MCAv: Hypoxia had no effect on resting MCAv (hypoxia:
P = 0.790 vs. normoxia), while augmenting FICO2 elevated
MCAv by 25621% during both normoxic and hypoxic conditions
(CO2: P = 0.001, interaction: P = 0.681).
Ventilatory variables. Resting PETCO2 was lower with
hypoxia (hypoxia: P = 0.001), while it was higher with augmented
FICO2 (CO2: P,0.001, interaction: P = 0.224). There was an
interaction between the effects of hypoxia and augmenting FICO2
on resting PETO2 (interaction: P = 0.004). Post-hoc analysis shows
that PETO2 was lowered with hypoxia during both control and
augmented FICO2 conditions (P,0.001
B vs. normoxia for both),
while augmenting FICO2 elevated resting PETCO2 by a greater
extent in normoxia (by 2065 mm Hg, P,0.001B vs. control
normoxia) compared to in hypoxia (by 1064 mm Hg, P,0.001B
vs. control hypoxia). Resting V
:
E was elevated by hypoxia
(P = 0.008 vs. normoxia) and augmented FICO2 (CO2:
P,0.001, interaction: P = 0.848). There was an interaction
between the effect of hypoxia and augmenting FICO2 on V
:
CO2
(interaction: P = 0.003). Post-hoc t-tests showed that hypoxia
elevated V
:
CO2 during control (P,0.001
B vs. control normoxia)
but not during augmented FICO2 (P = 0.832
B vs. augmented
FICO2 in normoxia). Accordingly, V
:
CO2 appeared to be lower
with augmented FICO2 in hypoxia (P,0.001
B vs. control hypoxia)
but not in normoxia (P = 0.131B vs. control normoxia). No
differences were observed in V
:
O2 with either hypoxia or
augmented FICO2 (main effects: P = 0.217 & P = 0.127, respec-
tively, interaction: P = 0.575).
Cardiovascular variables. Hypoxia elevated resting HR
(hypoxia: P,0.001 vs. normoxia); there was a slight but non-
significant tendency for augmenting FICO2 to attenuate this
increase in HR (CO2: P = 0.886, interaction: P = 0.059). The effect
of hypoxia and augmented FICO2 on resting SpO2 interacted with
each other (interaction: P = 0.004). Specifically, post-hoc analysis
found SpO2 to be lower with hypoxia during both control and
augmented FICO2 conditions (P,0.001
B vs. normoxia for both).
Meanwhile, augmenting FICO2 selectively elevated resting SpO2
in hypoxia (P,0.001B vs. control hypoxia), but not in normoxia
(P = 0.615B vs. control normoxia). No changes were observed in
resting MAP with either hypoxia or augmenting FICO2 (main
effects: P = 0.809 and P = 0.123, respectively, interaction:
P = 0.370).
Exercise
Performance. Hypoxia lowered maximal exercise capacity
by 26% (251615 W vs. 338621 W, hypoxia vs. normoxia,
hypoxia: P = 0.001), whereas there was a tendency for maximal
exercise capacity to be lowered with augmented FICO2 (CO2:
P = 0.091, interaction: P = 0.397). Specifically, maximal exercise
capacity tended to be lower by 4% in normoxia (332666 W vs.
345666 W, augmented FICO2 vs. control, P = 0.052
B), while no
trend was observed in hypoxia (248648 W vs. 256648 W,
P = 0.252B).
Ventilatory variables (Fig. 1A, 1B & 2A–D). During
incremental exercise, the effect of augmenting FICO2 on PETCO2
was greater in hypoxia compared to normoxia (interaction:
P,0.001). Post-hoc analysis revealed that throughout exercise,
hypoxia lowered PETCO2 during control by a greater extent than
during augmented FICO2 (1063 mmHg vs. 563 mmHg,
P,0.001B vs. normoxia for both). Meanwhile, augmenting FICO2
elevated PETCO2 by a lesser extent in normoxia compared to in
hypoxia (863 mmHg vs. 1463 mmHg, P,0.001B vs. control for
both). In contrast, hypoxia blunted the effect of augmenting
FICO2 on PETO2 (interaction: P,0.001). Post-hoc comparisons
found hypoxia lowered PETO2 by 4962 mmHg during control
and by 5464 mmHg during augmented FICO2 conditions
(P,0.001B vs. normoxia for both). Furthermore, augmenting
FICO2 increased PETO2 by 1563 mmHg in normoxia and by
1063 mmHg in hypoxia (P,0.001B vs. control for both).
During incremental exercise, both hypoxia and augmenting
FICO2 elevated V
:
E (main effect: P,0.001 for both, interaction:
P = 0.188). At exhaustion, V
:
E reached 74612% of estimated
maximal voluntary ventilation (MVV) in normoxia and 69611%
in hypoxia [26].
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MCAv (Fig. 1C, 2E & 2F). During incremental exercise,
there was a significant interaction between the effect of hypoxia
and augmenting FICO2 (interaction: P = 0.010). Post-hoc analysis
revealed that hypoxia elevated MCAv during control (P = 0.002B
vs. control normoxia), but not during augmented FICO2 condition
(P = 0.429B vs. augmented FICO2 in normoxia). Meanwhile,
augmenting FICO2 selectively elevated MCAv during incremental
exercise in normoxia (P,0.001B vs. control normoxia), but not in
hypoxia (P = 0.145B vs. control hypoxia).
Oxygen saturation (Fig. 1D, 2G & 2H). The effect of
augmenting FICO2 on SpO2 during exercise was enhanced in
hypoxia (interaction: P,0.001). As such, post-hoc analysis showed
that hypoxia lowered SpO2 by 2666% during control condition
(P,0.001B vs. control normoxia) and by 1566% during
augmented FICO2 condition (P,0.001
B vs. augmented FICO2
in normoxia). Meanwhile, augmenting FICO2 elevated SpO2 by
1265% in hypoxia (P,0.001B vs. control hypoxia), but not in
normoxia (P = 0.615B vs. control normoxia).
Metabolism (Fig. 1E, 1F & 3A–D). Hypoxia lowered both
V
:
O2 and V
:
CO2 throughout exercise (hypoxia: P,0.001 vs.
normoxia for both), while augmented FICO2 had no effect on
these variables (CO2: P = 0.628 & P = 0.544, respectively, inter-
action: P = 0.954 & P = 0.304).
Cardiovascular variables (Fig. 1G, 3E & 3F). During
exercise, the effect of hypoxia on HR was offset by the effect of
augmenting FICO2 (interaction: P = 0.003). Accordingly, post-hoc
t-tests found HR to be higher with hypoxia during control
(P = 0.001B vs. control normoxia), but not during the augmented
FICO2 (P = 0.360
B vs. augmented FICO2 in normoxia). There
were trends for augmenting FICO2 to elevate HR during exercise
in normoxia (P = 0.075B vs. control normoxia) and lower HR in
hypoxia (P = 0.019B vs. control hypoxia).
Rate of perceived exertion (Fig. 1H, 3G & 3H). There was
an interaction between effects of hypoxia and augmenting FICO2
on RPE (interaction: P = 0.045). As a result, a post-hoc t-tests
found a tendency for RPE to be elevated with augmented FICO2
in normoxia (P = 0.038B vs. control normoxia), but not in hypoxia
(P = 0.598B vs. control hypoxia). Hypoxia had no effect on RPE
during control or augmenting FICO2 (P = 0.735
B & P = 0.180B vs.
normoxia, respectively).
RC and V
:
E-slope to exercise (Fig. 4 & 5). During
exercise, the onset of RC occurred at lower power output in
hypoxia compared to in normoxia (by 86636 W, Hypoxia:
P,0.001). Likewise, the onset of RC occurred at lower power
output with augmenting FICO2 compared to control conditions
(CO2: P = 0.015; interaction: P = 0.176). Meanwhile, there was an
interaction between the effect of hypoxia and augmenting FICO2
on V
:
E at RC (interaction: P = 0.021). Post-hoc analysis revealed
that hypoxia tended to elevate V
:
E at RC under the augmented
FICO2 condition (P = 0.027
B vs. augmented FICO2 in normoxia),
but not during the control condition (P = 0.112B vs. control
normoxia). Augmenting FICO2 selectively increased V
:
E at RC in
hypoxia (by 23.95621.70 L/min, P = 0.007B vs. control hypoxia),
but not in normoxia (P = 0.847B vs. control normoxia). The effect
of hypoxia and augmenting FICO2 interacted with each other on
the V
:
E-slope to exercise (the slope of V
:
E rise against power) below
RC (interaction: P = 0.043). As such, hypoxia elevated the V
:
E
slope to exercise below RC during both control (by 30613%,
P,0.001B vs. control normoxia) and augmented FICO2 condition
(by 93678%, P = 0.001B vs. augmented FICO2 in normoxia).
Augmenting FICO2 lowered the V
:
E slope below RC during
normoxia (by 27614%, P = 0.001B vs. control normoxia), but not
during hypoxia (P = 0.786B vs. control hypoxia). In contrast, no
differences were observed in the V
:
E slope to exercise above RC
with either hypoxia or augmenting FICO2 (hypoxia: P = 0.256,
CO2: P = 0.155, interaction: P = 0.585).
Discussion
Augmenting FICO2 elevated CBF during incremental exercise
in normoxia, but, unexpectedly, it did not during hypoxia.
Furthermore, we found no improvement in exercise capacity with
Table 1. Effect of hypoxia and augmented FICO2 on resting respiratory, cerebrovascular and cardiovascular variables.
Normoxia Hypoxia
Control
Augmented
FICO2 Control
Augmented
FICO2
Ventilatory
PETCO2 (mmHg) 36 6 3 43 6 2* 32 6 2
{ 40 6 2*{
PETO2 (mmHg) 96 6 4 116 6 4* 45 6 3
{ 55 6 3*{
V
:
E (L/min) 11.6 6 1.8 24.1 6 5.1* 16.5 6 2.4
{ 28.5 6 5.5*{
V
:
O2 (ml/min) 350 6 64 394 6 63 346 6 91 375 6 75
V
:
CO2 (ml/min) 320 6 67 285 6 51 444 6 85
{ 282 6 66*
Cerebrovascular
MCAv (cm/s) 54 6 10 67 6 10* 54 6 12 66 6 16*
Cardiovascular
HR (b/min) 70 6 7 74 6 13 88 6 7 84 6 7*
MAP (mmHg) 90 6 7 99 6 11 90 6 14 100 6 9
SpO2 (%) 97 6 1 98 6 1 85 6 5
{ 91 6 3*{
Values are mean 6 SD.
*different from control (P,0.05);
{different from normoxia (P,0.05).
N = 10 for all variables except VO2 and VCO2 where N= 9.
doi:10.1371/journal.pone.0081130.t001
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augmented FICO2 during either normoxia or hypoxia. While the
roles of hypercapnia and hypoxia in the regulation of CBF during
rest have been extensively studied, their effects on cerebrovascular
control during exercise are less well documented [see [27] for
review]. During exercise, studies have found enhanced CBF
response to hypercapnia [28], while the CBF response to
hypocapnia remained unchanged [29]. During incremental
exercise, we observed higher MCAv during both control hypoxia
and augmented FICO2 in normoxia (Fig. 1C). However, in
contrast to the findings by Subudhi et al., [15], we observed no
further increase in MCAv with augmented FICO2 in hypoxia. The
discrepancies between these findings could potentially be account-
ed for by the differences in the experimental setup and/or the level
of hypercapnia achieved. In the study by Subudhi et al., [15],
Figure 1. Effect of hypoxia and augmented FICO2 on mean respiratory, cerebrovascular, metabolic and cardiac variables and
perceived effort of exertion during incremental cycling to exhaustion. Values expressed as mean 6 SD. * different from control (P,0.05);
{ different from normoxia (P,0.05); 1 trend for a difference (P,0.10).
doi:10.1371/journal.pone.0081130.g001
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Figure 2. Effect of hypoxia and augmented FICO2 on group respiratory, cerebrovascular variables and peripheral O2 saturation
during incremental cycling to exhaustion. Left panels: group data in normoxia (mean 6 SD); right panels: group data in hypoxia. Note: these
graphs are only intended for visualizing the changes in physiological parameters during incremental cycling. Statistical analyses were carried out
using the average variable during the exercise session (see Figure 1).
doi:10.1371/journal.pone.0081130.g002
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Figure 3. Effect of hypoxia and augmented FICO2 on metabolic variables, heart rate, and perceived effort of exertion during
incremental cycling to exhaustion. Left panels: group data in normoxia (mean6 SD); right panels: group data in hypoxia. Note: these graphs are
only intended for visualizing the changes in physiological parameters during incremental cycling. Statistical analyses were carried out using the
average variable during the exercise session (see Figure 1).
doi:10.1371/journal.pone.0081130.g003
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PETCO2 was clamped at 50 mmHg throughout exercise, while
our subjects’ PETCO2 were on average, ,46 and ,43 mmHg in
normoxia and hypoxia respectively (Fig. 1A), reaching ,53 and
,47 mmHg at maximal exercise intensity (Fig. 2A & 2B).
Meanwhile, using our Altitrainer setup, Siebenmann et al., [16]
were able to increase MCAv during incremental exercise in
moderate hypobaric hypoxia (3,454 m) by clamping PETCO2 at
40 mmHg in altitude sojourners. We deem it unlikely that
differences in experimental setup are sufficient to account for
these discrepant findings between the three studies. An alternative
explanation is the potential influence of (partial) altitude acclima-
tization [30]. Subudhi et al., [15] examined the effect of CO2
clamping on competitive cyclists living and training at 1,650 m,
therefore already acclimatized to exercise at moderate altitude.
Likewise, the subjects in Siebenmann et al., [16] had spent one
night at altitude. In contrast, the subjects in our study had not
been exposed to altitude .1000 m in the 2 months prior the
study. Since acclimatization to altitude augments the cerebrovas-
cular responsiveness to CO2 [17], the increase in CBF observed by
both Subudhi et al., [15] and Siebenmann et al., [16] may
therefore be due to a partial state of acclimatization to altitude.
Cerebral O2 delivery and performance in hypoxia
Contrary to our first hypothesis, augmenting FICO2 during
incremental exercise in normobaric hypoxia failed to improve
aerobic exercise capacity. This finding corroborates recent
findings in milder (hypobaric) hypoxic conditions [15,16]. The
relationship between cerebral deoxygenation and exercise perfor-
mance in normoxia [13] and hypoxia [6–12] is therefore unlikely
to be causally related to the loss of aerobic capacity in hypoxia.
However, it cannot be excluded that augmenting FICO2
introduces limits that overrule the potential benefit of improved
cerebral CO2 delivery. Siebenmann et al., [16] argued that
inspired CO2 may exacerbate the metabolic acidosis associated
with heavy exercise, shifting the oxyhemoglobin curve rightward,
decreasing SaO2, thus limiting peak V
:
O2. In agreement, our
results show a reduction in average heart rate in hypoxia (Fig. 1G)
and a tendency for maximal exercise capacity to be actually
impaired with augmented FICO2 (P = 0.091), as also reported
elsewhere [15,16]. In agreement with Subudhi et al., [15], we
found the participants’ RPE to increase more rapidly with
augmented FICO2 in normoxia (Fig. 3G), in parallel with the
increase in ventilation (Fig. 2C). But contrary to Siebenmann et
al., [16], our findings of higher SpO2 with augmented FICO2 in
hypoxia throughout submaximal exercise intensities, and similar
SpO2 at exhaustion (Fig. 2H), which exclude a right-ward shift in
the oxyhemoglobin curve would have limited pulmonary oxygen
uptake.
Limits to cerebral vasodilation
While controversy remains, there is a large body of literature
suggesting that nitric oxide, prostanoids and C-natriuretic peptide
are involved in the cerebral vasodilatory responses to both
hypercapnia and hypoxia through a number of intermediate
interacting/co-activating pathways [31]. We speculate that if one
chemical stimulus, such as hypoxia, is of sufficient magnitude to
exhaust the cerebral vessels’ capacity to vasodilate, thereby
reaching maximal diameter of the vessels, then any additional
stimuli would have no further effect on cerebrovascular resistance.
Our data indicate that the CBF response to hypoxia is enhanced
during exercise compared to rest, while adding CO2 to the
inspired gas during exercise only elevates CBF during normoxia,
Figure 4. Effect of hypoxia and augmented FICO2 on respiratory compensation threshold and ventilatory response to exercise
during incremental cycling to exhaustion. Values expressed as mean 6 SD. * different from control (P,0.05); { different from normoxia
(P,0.05); 1 trend for a difference (P,0.10).
doi:10.1371/journal.pone.0081130.g004
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but not during severe hypoxia (Fig. 1C). The ‘normal’ cerebro-
vascular reactivity to hypercapnia thus appears to be abolished
during exercise in severe hypoxia (Fig. 2F). In support, we found
no difference between the MCAv values between augmented
FICO2 in normoxia and control hypoxia (P = 0.193). Such
exhaustion of the cerebral vessels’ vasodilatory reserve would
account for the lack of change in MCAv with augmented FICO2
during sub-maximal exercise in hypoxia. Mardimae et al., [32]
demonstrated a synergistic role of CO2 and hypoxia on the control
of CBF at rest whereas our results would favor a negative effect,
whereby the presence of severe hypoxia appears to attenuate the
effect of hypercapnia on the cerebral vessels. Our data indicates
that during incremental exercise in hypoxia, the role of
hypercapnia in the regulation of cerebrovascular tone appears to
be diminished – at least in an unacclimatized population.
However, we cannot exclude the possibility that there might be
regional differences in the cerebral vessel response to hypoxia and
hypercapnia, which could display additive or synergistic interac-
tions between the two chemical stimuli. Furthermore, the effect of
combining hypoxia and hypercapnia on cerebral metabolism is
unknown. Given the limited literature on this topic, further studies
on the effect of hypoxia, hypercapnia and acclimatization status on
regulation of cerebrovascular tone and therefore cerebral O2
delivery during exercise in altitude is certainly warranted.
Chemoreception and exercise hyperpnea
The regulation of exercise hyperpnea has been extensively
studied during the past 100 years [see [33–37] for reviews].
Nevertheless, the role of chemoreception in the regulation of
exercise hyperpnea, especially during heavy exercise remains
controversial [38,39]. To date, only a handful of studies have
examined the effect of chemoreceptor stimulation with CO2 alone
[3,14,25,40,41] or the combined effects of hypoxia and hypercap-
nia on exercise hyperpnea [42]. Our second hypothesis stated that
increasing PETCO2 and decreasing PETO2 would stimulate the
chemoreceptors and lead to an increase in the ventilatory response
to exercise. We found that hypoxia and augmented FICO2 had an
additive effect on exercise hyperpnea below the RC threshold
(Fig. 4C). As reported before in conditions of normoxia [14],
adding CO2 to the inspirate during normoxic and hypoxic
conditions indeed increased ventilation at rest and during
incremental exercise (Table 1 & Fig. 5). However, at higher
intensities, above the RC threshold, this effect progressively
lessened, in spite of a progressive increase in PETCO2, again
similarly to what we found before in normoxia [14]. Hypoxia per se
augmented the ventilatory response to incremental exercise (the
rate of ventilation increase during exercise) below the RC
threshold, while augmented FICO2 attenuated this rate of increase
(Fig. 5). Hypoxia shifted the RC threshold to lower exercise
intensities, which is further exacerbated with augmented FICO2
(Fig. 4A & 5B). No differences were observed in the slope of the
ventilatory response to exercise above the RC threshold between
any of the conditions (Fig. 4D). We thus confirm that below the
RC threshold both hypoxia and hypercapnia can modulate the
rate of ventilatory response to increasing exercise, presumably
through chemoreceptor stimulation. However, once above the
ventilatory compensation threshold, the chemoreflex ventilatory
responses are blunted.
Siebenmann et al., [16] suggested that, during heavy exercise in
hypoxia, the hyperventilation-induced hypocapnia might attenu-
ate ventilatory drive and limit the ventilatory response to exercise.
They further speculated that the mechanical constraints associated
with high intensity exercise ventilation may be reduced in
hypobaric hypoxia, while at the same time hypocapnia would be
more pronounced, so that a blunting effect of hypocapnia on V
:
E
would persist or become more pronounced. Since we performed
our experiments in normobaric conditions our results were not
influenced by differences in air density, neglecting the small
increases in N2 and CO2 in exchange of O2 in our inspirates. In
our young and active, but not-athletic subjects, mechanical
limitation would seem unlikely since maximal ventilation only
reached,70% of estimated MVV with augmented FICO2 both in
normoxia and hypoxia.
Methodological considerations
Although the present study provided the opportunity to
examine the effects of augmented FICO2 on CBF response and
exercise capacity during incremental exercise in hypoxia, an
important limitation of the present study, as of many other studies,
is the assumption that MCAv represents global CBF changes. Sato
et al., [43] recently found that blood flow in the middle cerebral
and internal carotid arteries declined from moderate (60%
V
:
O2max) to high intensity exercise (80% V
:
O2max), whilst blood
flow in the vertebral artery continued to increase at the higher
intensities. This led Vogiatzis et al., [11] to suggest that vertebral
artery blood flow may compensate for reductions of MCA blood
flow during near-maximal or maximal exercise. However, since
the relative contribution of the internal carotid artery (and
Figure 5. Effect of hypoxia and augmented FICO2 on respira-
tory compensation threshold and ventilatory response to
exercise during incremental cycling to exhaustion. A: group
data in normoxia (mean 6 SD); B: group data in hypoxia. * different
from control (P,0.05); { different from normoxia (P,0.05); 1 trend for a
difference (P,0.10).
doi:10.1371/journal.pone.0081130.g005
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therefore MCA) to global CBF remains relatively unchanged
(,65%) at high intensity exercise [43], we contend that MCAv is a
reasonable index of changes in global CBF during heavy exercise.
Further consideration when interpreting our MCAv data is the
potential influence of hypoxia and hypercapnia on the MCA
diameter. The cross-sectional area of the MCA was shown to
remain relatively unchanged within a wide range of changes in
PETCO2 [44–47] and during exposure to hypoxia similar to that
used in the present study (5,300 m) [48]. However, since no studies
have examined the effect of exercise on MCA diameter, nor when
superimposed with hypoxia and hypercapnia, we cannot exclude
the possibility MCA diameter might have increased in our study,
leading to an underestimation of the effect of augmented FICO2
or hypoxia on CBF. In addition, since we did not measure cerebral
tissue oxygenation, it is possible that we were unable to elevated
cerebral O2 delivery with our experimental setup. However, in the
present study, SpO2 was elevated with augmented FICO2
throughout exercise in hypoxia (Fig. 1D), while MCAv was
comparable between the control and augmented FICO2 condi-
tions (Fig. 1C). We would therefore expect cerebral O2 delivery,
which is the product of arterial O2 saturation and CBF, to be
elevated with augmented FICO2 in hypoxia, leading to increased
cerebral tissue oxygenation.
Another limitation of the present study is that we increased end-
tidal rather than arterial PCO2 during exercise, while it is known
that the end-tidal-arterial PCO2 gradient [49] varies with exercise
[50,51]. Using our setup, Siebenmann et al., [16] were successful
in clamping both end-tidal and arterial PCO2 at around
40 mmHg during incremental exercise in hypoxia. Therefore,
we believe it is likely that we were able to sufficiently elevate
PaCO2.
Finally, in the present study, we used a linear ramp protocol to
assess the effect of augmented FICO2 on the ventilatory response
during incremental exercise. It should be acknowledged that
during incremental exercise, lower peak V
:
O2 and work output is
obtained during ramp vs. step protocols [52], while the steepness
of the ramp (i.e., 10 W/min, 30 W/min or 50 W/min), pedaling
frequency and baseline workload can influence the onset of
ventilatory threshold, peak V
:
O2 and the V
:
O2-workload relation-
ship [53,54]. Therefore, our conclusions on the ventilatory
response to exercise should only be limited to the specific ramp
protocol (30 W/min) used in the present study. Furthermore, since
all the aforementioned studies [15,16] only looked at aerobic
capacity using incremental exercise tests until voluntary exhaus-
tion, which have limited ecological validity [55], it remains to be
investigated if increasing MCAv by augmenting FICO2 during
steady-state sub-maximal endurance exercise such as a time trial
could improve performance in hypoxia, as time trial exercise
provide a more accurate simulation of physiological responses
during actual competitions [56] and correlate well with actual race
performance [57].
Conclusions
We report two novel findings. Firstly, augmenting FICO2
increases cerebral blood flow during sub-maximal exercise in
normoxia, but not in hypoxia. This finding indicates that the
‘normal’ cerebrovascular response to hypercapnia is impaired
during exercise in hypoxia, possibly due to an exhaustion of
cerebral vasodilatory reserve. Secondly, above the ventilatory
recruitment threshold, both in normoxia and hypoxia, the
chemoreflex ventilatory responses are blunted.
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